These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 16765356)

  • 21. Interpretation of lipoprotein-associated phospholipase A2 levels is influenced by cardiac disease, comorbidities, extension of atherosclerosis and treatments.
    Charniot JC; Khani-Bittar R; Albertini JP; Giral P; Cherfils C; Cosson C; Guillerm E; Leprince P; Gandjbakhch I; Bonnefont-Rousselot D
    Int J Cardiol; 2013 Sep; 168(1):132-8. PubMed ID: 23103135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of Lp-PLA2 with digital reactive hyperemia, coronary flow reserve, carotid atherosclerosis and arterial stiffness in coronary artery disease.
    Ikonomidis I; Kadoglou NN; Tritakis V; Paraskevaidis I; Dimas K; Trivilou P; Papadakis I; Tzortzis S; Triantafyllidi H; Parissis J; Anastasiou-Nana M; Lekakis J
    Atherosclerosis; 2014 May; 234(1):34-41. PubMed ID: 24594367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipoprotein-associated phospholipase A2.
    McConnell JP; Hoefner DM
    Clin Lab Med; 2006 Sep; 26(3):679-97, vii. PubMed ID: 16938590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. OxLDL stimulates lipoprotein-associated phospholipase A2 expression in THP-1 monocytes via PI3K and p38 MAPK pathways.
    Wang WY; Li J; Yang D; Xu W; Zha RP; Wang YP
    Cardiovasc Res; 2010 Mar; 85(4):845-52. PubMed ID: 19910444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lentiviral-mediated RNA interference of lipoprotein-associated phospholipase A2 ameliorates inflammation and atherosclerosis in apolipoprotein E-deficient mice.
    Zhang H; Zhang J; Shen D; Zhang L; He F; Dang Y; Li L
    Int J Mol Med; 2013 Mar; 31(3):651-9. PubMed ID: 23338278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Higher lipoprotein-associated phospholipase A2 levels are associated with coronary atherosclerosis documented by coronary angiography.
    Dohi T; Miyauchi K; Ohkawa R; Nakamura K; Thuboi S; Ogita M; Miyazaki T; Nishino A; Yokoyama K; Kurata T; Yatomi Y; Daida H
    Ann Clin Biochem; 2012 Nov; 49(Pt 6):527-33. PubMed ID: 22933444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential Expression of Lipoprotein-Associated Phospholipase A2 in Monocyte Subsets: Impact of Uremia and Atherosclerosis.
    Ulrich C; Trojanowicz B; Fiedler R; Kohler F; Wolf AF; Seibert E; Girndt M
    Nephron; 2017; 135(3):231-241. PubMed ID: 27992874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxidized LDL induces procoagulant profiles by increasing lysophosphatidylcholine levels, lysophosphatidylethanolamine levels, and Lp-PLA
    Kim M; Yoo HJ; Lee D; Lee JH
    Nutr Metab Cardiovasc Dis; 2020 Jun; 30(7):1137-1146. PubMed ID: 32456947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High density lipoprotein suppresses lipoprotein associated phospholipase A2 in human monocytes-derived macrophages through peroxisome proliferator-activated receptor-γ pathway.
    Han GP; Ren JY; Qin L; Song JX; Wang L; Chen H
    Chin Med J (Engl); 2012 Dec; 125(24):4474-80. PubMed ID: 23253723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipoprotein-associated phospholipase A2 and coronary calcification. The Rotterdam Coronary Calcification Study.
    Kardys I; Oei HH; Hofman A; Oudkerk M; Witteman JC
    Atherosclerosis; 2007 Apr; 191(2):377-83. PubMed ID: 16678183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipoprotein-associated phospholipase A
    Öngen B; Kalkan Uçar S; Levent E; Azarsız E; Koloğlu T; Çoker M; Sözmen E; Sağın FG
    Ann Clin Biochem; 2017 Sep; 54(5):539-547. PubMed ID: 27614353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Lipoprotein associated phospholipase A2].
    Rubinstein A; Izkhakov E
    Harefuah; 2011 Feb; 150(2):136-40, 205. PubMed ID: 22164942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between Lp-PLA2 and coronary artery disease: focus on its relationship with lipoproteins and markers of inflammation and hemostasis.
    Khuseyinova N; Imhof A; Rothenbacher D; Trischler G; Kuelb S; Scharnagl H; Maerz W; Brenner H; Koenig W
    Atherosclerosis; 2005 Sep; 182(1):181-8. PubMed ID: 16115490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipoprotein-associated phospholipase A2 (Lp-PLA2) and tumor necrosis factor-alpha (TNF-α) and their relation to premature atherosclerosis in β-thalassemia children.
    Ragab SM; Safan MA; Obeid OM; Sherief AS
    Hematology; 2015 May; 20(4):228-38. PubMed ID: 25056687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Replacing with whole grains and legumes reduces Lp-PLA2 activities in plasma and PBMCs in patients with prediabetes or T2D.
    Kim M; Jeung SR; Jeong TS; Lee SH; Lee JH
    J Lipid Res; 2014 Aug; 55(8):1762-71. PubMed ID: 24904022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) in acute coronary syndrome: relationship with low-density lipoprotein cholesterol.
    Jabor B; Choi H; Ruel I; Hafiane A; Mourad W; Genest J
    Can J Cardiol; 2013 Dec; 29(12):1679-86. PubMed ID: 24267807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease.
    Sabatine MS; Morrow DA; O'Donoghue M; Jablonksi KA; Rice MM; Solomon S; Rosenberg Y; Domanski MJ; Hsia J;
    Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2463-9. PubMed ID: 17766330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Lp-PLA2, a biomarker of vascular inflammation and vulnerability of atherosclerosis plaques].
    Bonnefont-Rousselot D
    Ann Pharm Fr; 2016 May; 74(3):190-7. PubMed ID: 26499399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Community-based statins and advanced carotid plaque: Role of CD163 positive macrophages in lipoprotein-associated phospholipase A
    Otsuka F; Zhao X; Trout HH; Qiao Y; Wasserman BA; Nakano M; Macphee CH; Brandt M; Krug-Gourley S; Guo L; Ladich ER; Cheng Q; Davis HR; Finn AV; Virmani R; Kolodgie FD
    Atherosclerosis; 2017 Dec; 267():78-89. PubMed ID: 29101839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipoprotein-associated phospholipase A2 as a biomarker of coronary heart disease and a therapeutic target.
    Packard CJ
    Curr Opin Cardiol; 2009 Jul; 24(4):358-63. PubMed ID: 19417639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.